In previous studies of inactivated poliomyelitis vaccine given to young infants, whether alone or in combination with other antigens such as diphtheria, tetanus and pertussis, the suppressive effect of maternal antibodies on active immunization has been repeatedly described. Inactivated measles vaccine, however, has been studied primarily in preschool or school children and very little information is available concerning the serologic response of young infants to it alone or combined with other antigens. The purpose of this study was to determine the serologic response of 3 and 5 months old infants to a combined inactivated measles-poliomyelitis vaccine.
bined preparation. Blood specimens were taken before and one month after the primary series, and before and two weeks after booster. In addition, a small number of children were bled again 6 months following booster. Neutralizing antibodies for both viruses were determined in tissue culture tests* and, in addition, fluorescent antibody determinations were made using the indirect method. Reactions Forty-seven of the infants in one clinic were followed for reactions to the vaccine by having the mothers report on specific reactions. Twenty infants showed fussiness, 16 had slight fever, or warmness, 4 lacked appetite and 6 showed slight or moderate local reactions at the si~e of injection. Many of the reactions followed the second dose of vaccine. The 9 infants who received live, attenuated vaccine for their booster were examined by a physician daily from the 5th through the 10th day following injection. These results are discussed later. * Neutralization tests for measles virus were performed in the laboratories of Chgs. Pfizer and Co. in Terre HouSe. Indiana.
Results
The neutralizing antibody titers for poliomyelitis before and after both primary and booster immunization are shown in Fig. 1 . It can be seen that many infants retained maternal antibodies at the third month of life and most of these failed to respond to primary vaccination with increased antibody titers. This confirms previous observations of the suppressive effect of passive antibodies on active immunization. In contrast, very few infants had maternal antibodies in high titer at 5 months of life illustrating the importance of the two additional months in allowing further passive antibody decay. Most infants with maternal antibodies in low or in nondetectable titer responded with antibody production although the type III antigen appeared to be the weakest of the 3 types. No apparent difference existed in the response of infants in the two age groups if uncomplicated by the presence of maternal antibodies. The serologic response to booster inoculation was unusually good when compared with previous studies which showed that suppression of primary immunization fie- quently resulted in unsatisfactory response to booster injections. In the present study only two infants were left without detectable antibodies following this stimulus. Furthermore, most of the titers attained following booster were quite high suggesting excellent protection against the disease. Thirty of the 42 infants (71%) receiving their first injection at the age of 3 months had maternal antibodies for measles virus in titers of 1:6 or greater. (Table 1 .) Only 3 of these responded to the primary series with increased titers. In contrast 10 of the 12 infants with titers of less than 1 : 6 responded. Only 9 of 23 infants (39%) injected first at the age of 5 months still had passive antibodies of 1 : 6 or greater and none of these responded. In contrast, all 14 with lower titers showed an increase. Thus, 60% of all the infants receiving vaccine at the age of 5 months responded immunelogically in contrast to only 28% of the total number started two months earlier. The significance of passive antibody suppression of primary response is illustrated by the fact that two of these non-responding children deVeloped clinical measles, 6 weeks and 5 months respectively, following the third injection of the primary series. Fig. 2 shows the neutralizing antibody titers for measles virus before and after primary and secondary immunization. Twenty-four of the 23* 52 children bled at the time of booster showed retention of antibodies, some in high Citer, 9 and 11 months after the primary series. This number might well have been considerably higher but for the fact that 16 of the 28 (57%) without antibodies at this time were non-responders to primary series by virtue of maternal antibody suppression and did not have antibodies to retain.
The response to booster injection must be considered as highly satisfactory since only 2 children failed to show increased antibodies. Both of these, incidently, were non-responders to the primary series. In general iit ~ ~ the titers of antibody in post.booster sera were found to be high. No apparent difference in Citers was detected between those children who had received their first injection at the age of 3 months or at 5 months. The 9 children who were given live, attenuated virus vaccine for their boosters responded with Citers very similar to those found in children receiving killed vaccine. Table 2 presents the individual antibody Citers detected in these individuals together with the reactions seen. In 4 of the 9, an elevated temperature was recorded, one had a moderate local reaction at the site of inoculation, another, a runny nose, and still another showed a transient rash and otitis media. Five were perfectly normal throughout the period of observation. On the basis of serologic and clinical response to booster it seems unlikely that either of the 2 children thought by their private physicians to have had measles following primary series were in fact accurately diagnosed.
